FOLH1 and prostate cancer: The present data show that administration of intravenous furosemide concurrent with tracer injection considerably reduces tracer concentration in the urinary bladder in patients staged with PSMA PET/CT for prostate cancer, which is true for both 68Ga-PSMA-11 as well as 18F-DCFPyL.